U.S. Stem Cell, Inc. is a biotechnology company, which engages in the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its product, MyoCell, deals with the clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company was founded by Howard J. Leonhardt and Robert D. Lashinski on August 12, 1999 and is headquartered in Sunrise, FL.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of U.S. Stem Cell Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. U.S. Stem Cell Inc market cap is $64,200.00.
What is the 52-week high for U.S. Stem Cell Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. U.S. Stem Cell Inc 52 week high is $0.0002 as of October 10, 2025.
What is the 52-week low for U.S. Stem Cell Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. U.S. Stem Cell Inc 52 week low is $0.00 as of October 10, 2025.
What is U.S. Stem Cell Inc stock price today?
U.S. Stem Cell Inc stock price today is $0.0001.
What was U.S. Stem Cell Inc stock price yesterday?
U.S. Stem Cell Inc stock price yesterday was $0.0001.
What is the 50-day moving average of U.S. Stem Cell Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. U.S. Stem Cell Inc 50-day moving average is $0.0001.